Showing 541 - 560 results of 805 for search '"Demyelinating disease"', query time: 0.12s Refine Results
  1. 541

    Sociodemographic and Illness-Related Indicators to Predict the Status of Neuromyelitis Optica Spectrum Disorder (NMOSD) Five Years after Disease Onset by Dena Sadeghi-Bahmani, Mahdi Barzegar, Omid Mirmosayyeb, Saeed Vaheb, Nasim Nehzat, Vahid Shaygannejad, Serge Brand

    Published 2022-01-01
    “…Background: Neuromyelitis Optica Spectrum Disorder (NMOSD) is an autoimmune demyelinating disease of the central nervous system. Currently, no factors have been identified to predict the long-term course of NMOSD. …”
    Get full text
    Article
  2. 542

    Association between vitamin D deficiency and multiple sclerosis- MRI significance: A scoping review by Shorouk Hajeer, Farah Nasr, Sanaa Nabha, Marie-belle Saab, Hayat Harati, Alban Desoutter, Elie Al Ahmar, Elias Estephan

    Published 2023-05-01
    “…Background/Objective: Multiple Sclerosis is a common demyelinating disease of the central nervous system. Several studies suggested a link between vitamin D deficiency and multiple sclerosis disease activity, which can be evaluated by magnetic resonance imaging. …”
    Get full text
    Article
  3. 543

    Personality traits of patients with multiple sclerosis and their correlation with anxiety and depression levels: A cross‐sectional case–control study by Amirali Ghahremani, Sahar Mosa Farkhani, Mahsa Baniasadi, Seyed Kaveh Hojjat, Hasan Namdar Ahmadabad, Davoud Salarbashi, Sepideh Elyasi, Najmeh Davoodian

    Published 2022-05-01
    “…Abstract Objective Multiple sclerosis is a chronic demyelinating disease of the central nervous system that can cause severe disability and impair the quality of life (QoL). …”
    Get full text
    Article
  4. 544
  5. 545

    Polysialic acid promotes remyelination in cerebellar slice cultures by Siglec-E-dependent modulation of microglia polarization by Lara-Jasmin Schröder, Lara-Jasmin Schröder, Hauke Thiesler, Lina Gretenkort, Thiemo Malte Möllenkamp, Martin Stangel, Martin Stangel, Viktoria Gudi, Herbert Hildebrandt, Herbert Hildebrandt

    Published 2023-07-01
    “…Multiple sclerosis is an inflammatory demyelinating disease of the central nervous system. Spontaneous restoration of myelin after demyelination occurs, but its efficiency declines during disease progression. …”
    Get full text
    Article
  6. 546

    Cellular inhibitor of apoptosis 2 (cIAP2) restricts neuroinflammation during experimental autoimmune encephalomyelitis by Debolina D. Biswas, Rebecca K. Martin, LaShardai N. Brown, Karli Mockenhaupt, Angela S. Gupta, Michael J. Surace, Anuj Tharakan, Jessie W. Yester, Reetika Bhardwaj, Daniel H. Conrad, Tomasz Kordula

    Published 2022-06-01
    “…Abstract Background Immune activation, neuroinflammation, and cell death are the hallmarks of multiple sclerosis (MS), which is an autoimmune demyelinating disease of the central nervous system (CNS). …”
    Get full text
    Article
  7. 547

    Brain region dependent molecular signatures and myelin repair following chronic demyelination by Grace Samtani, Grace Samtani, Sunja Kim, Danielle Michaud, Andrew E. Hillhouse, Joseph A. Szule, Kranti Konganti, Jianrong Li, Jianrong Li

    Published 2023-04-01
    “…Multiple sclerosis (MS) is the most prevalent demyelinating disease of the central nervous system, characterized by myelin destruction, axonal degeneration, and progressive loss of neurological functions. …”
    Get full text
    Article
  8. 548

    Locked‐in syndrome after central pontine myelinolysis, an outstanding outcome of two patients by Maïlys Chabert, Corentin Dauleac, Maude Beaudoin‐Gobert, Mélaine De‐Quelen, Sophie Ciancia, Timothée Jacquesson, Simon Bertrand, Emmanuel Vivier, Donatien De‐Marignan, Julien Jung, Nathalie Andre‐Obadia, Florent Gobert, François Cotton, Jacques Luauté

    Published 2024-03-01
    “…Abstract Objective Central pontine myelinolysis (CPM) is a rare demyelinating disease that affects the pons and which can cause extreme disabilities such as locked‐in syndrome (LIS) in the initial phase. …”
    Get full text
    Article
  9. 549

    Teriflunomide Inhibits JCPyV Infection and Spread in Glial Cells and Choroid Plexus Epithelial Cells by Bethany A. O’Hara, Gretchen V. Gee, Sheila A. Haley, Jenna Morris-Love, Charlotte Nyblade, Chris Nieves, Barbara A. Hanson, Xin Dang, Timothy J. Turner, Jeffrey M. Chavin, Alex Lublin, Igor J. Koralnik, Walter J. Atwood

    Published 2021-09-01
    “…Most of these disease-modifying therapies, except teriflunomide, carry the risk of progressive multifocal leukoencephalopathy (PML), a severely debilitating, often fatal virus-induced demyelinating disease. Because teriflunomide has been shown to have antiviral activity against DNA viruses, we investigated whether treatment of cells with teriflunomide inhibits infection and spread of JC polyomavirus (JCPyV), the causative agent of PML. …”
    Get full text
    Article
  10. 550
  11. 551

    CD4+ T cell mitochondrial genotype in Multiple Sclerosis: a cross-sectional and longitudinal analysis by Filipe Cortes-Figueiredo, Susanna Asseyer, Claudia Chien, Hanna G. Zimmermann, Klemens Ruprecht, Tanja Schmitz-Hübsch, Judith Bellmann-Strobl, Friedemann Paul, Vanessa A. Morais

    Published 2024-03-01
    “…Abstract Multiple Sclerosis (MS) is a chronic autoimmune demyelinating disease of the central nervous system (CNS), with a largely unknown etiology, where mitochondrial dysfunction likely contributes to neuroaxonal loss and brain atrophy. …”
    Get full text
    Article
  12. 552

    Case report: A case of acute disseminated encephalomyelitis after SARS-CoV-2 infection in pediatric patients by Francesca Cautilli, Mariavittoria Feleppa, Massimiliano Valeriani, Laura Papetti, Gabriele Monte, Fabio Midulla, Alberto Spalice

    Published 2023-02-01
    “…Acute disseminated encephalomyelitis (ADEM) is an inflammatory demyelinating disease of the central nervous system. Typically, it presents in childhood and occurs 1 or 2 weeks after infection or vaccination.Case presentationWe present the case of a 12-year-old boy who developed ADEM, 10 days after an asymptomatic SARS-CoV-2 infection. …”
    Get full text
    Article
  13. 553

    Siponimod Attenuates Neuronal Cell Death Triggered by Neuroinflammation via NFκB and Mitochondrial Pathways by Mikel Gurrea-Rubio, Qin Wang, Elizabeth A. Mills, Qi Wu, David Pitt, Pei-Suen Tsou, David A. Fox, Yang Mao-Draayer

    Published 2024-02-01
    “…Multiple sclerosis (MS) is the most common autoimmune demyelinating disease of the central nervous system (CNS), consisting of heterogeneous clinical courses varying from relapsing-remitting MS (RRMS), in which disability is linked to bouts of inflammation, to progressive disease such as primary progressive MS (PPMS) and secondary progressive MS (SPMS), in which neurological disability is thought to be linked to neurodegeneration. …”
    Get full text
    Article
  14. 554

    ACT001 Relieves NMOSD Symptoms by Reducing Astrocyte Damage with an Autoimmune Antibody by Hongen Li, Mo Yang, Honglu Song, Mingming Sun, Huanfen Zhou, Junxia Fu, Di Zhou, Wenhao Bai, Biyue Chen, Mengying Lai, Hao Kang, Shihui Wei

    Published 2023-02-01
    “…Neuromyelitis optica spectrum disorder (NMOSD) is a central nervous system inflammatory demyelinating disease, the pathogenesis of which involves autoantibodies targeting the extracellular epitopes of aquaporin-4 on astrocytes. …”
    Get full text
    Article
  15. 555

    Two case reports and a systematic review of the literature on adult cerebral cortical encephalitis with anti-myelin oligodendrocyte glycoprotein antibody by Meihui Xu, Chi Ma, Ming Dong, Chunjie Guo, Simin Yang, Yue Liu, Xu Wang

    Published 2023-07-01
    “…Background and purposeMyelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) has gained recognition in recent years as an immune-mediated inflammatory demyelinating disease of the central nervous system. The clinical features and prognosis of MOGAD adult cerebral cortical encephalitis (adult CCE) have not been fully elucidated. …”
    Get full text
    Article
  16. 556

    Obesity induced gut dysbiosis contributes to disease severity in an animal model of multiple sclerosis by Shailesh K. Shahi, Sudeep Ghimire, Peter Lehman, Ashutosh K. Mangalam, Ashutosh K. Mangalam, Ashutosh K. Mangalam

    Published 2022-09-01
    “…BackgroundMultiple sclerosis (MS) is an inflammatory and demyelinating disease of the CNS. The etiology of MS is complex, and results from the interaction of multiple environmental and genetic factors. …”
    Get full text
    Article
  17. 557

    Alpha-asaronol promoted oligodendrocyte precursor cell differentiation and improved myelination as an activator PPARγ by Zhaowei Feng, Zixuan Gao, Renyu Kong, Tao Zhuang, Jing Liu, Ting Liu, Xiaohui Zheng, Yajun Bai, Ruiqin Yao

    Published 2023-07-01
    “…Preterm white matter injury (PWMI), characterized by oligodendrocyte precursor cell (OPC) differentiation disorder and dysmyelination, is a prevalent demyelinating disease of the central nervous system in premature infants, necessitating the development of mitigating strategies. …”
    Get full text
    Article
  18. 558

    Characterisation of astrocyte diversity in the multiple sclerosis motor cortex by Yee, S

    Published 2022
    “…<p>Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system where neurodegeneration often leads to irreversible disability. …”
    Thesis
  19. 559

    Clinical and Radiological Characterization of Progressive Multifocal Leukoencephalopathy in HIV-Infected Patients: A Retrospective Analysis and Review of the Literature by Luís Augusto, Nélia Neves, Carina Reis, Cândida Abreu, António Sarmento

    Published 2015-04-01
    “… Introduction: Progressive multifocal leukoencephalopathy is a demyelinating disease of the central nervous system caused by John Cunningham virus, mostly associated with immunodeficiency conditions, such as the human immunodeficiency virus infection. …”
    Get full text
    Article
  20. 560

    Value contribution of blood-based neurofilament light chain as a biomarker in multiple sclerosis using multi-criteria decision analysis by Enric Monreal, Pilar Díaz Ruiz, Isabel López San Román, Alfredo Rodríguez-Antigüedad, Miguel Ángel Moya-Molina, Ana Álvarez, Elena García-Arcelay, Jorge Maurino, John Shepherd, Álvaro Pérez Cabrera, Luisa María Villar

    Published 2024-04-01
    “…IntroductionMultiple sclerosis (MS) is a chronic autoimmune demyelinating disease that represents a leading cause of non-traumatic disability among young and middle-aged adults. …”
    Get full text
    Article